Related Experiment Video
Updated: Aug 12, 2026
07:48
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock
Regulatory Peptides
|October 1, 1983
Summary
Thyrotropin releasing hormone (TRH) stimulates cardiorespiratory function and can reverse endotoxic shock hypotension in rats. Its therapeutic potential in shock treatment is supported by findings on its mechanisms and sites of action within the brain.
Area of Science:
- Cardiovascular Physiology
- Neuroendocrinology
- Pharmacology
Background:
- Thyrotropin releasing hormone (TRH) plays a role in regulating cardiorespiratory function.
- Endotoxemia can lead to severe hypotension and cardiovascular dysfunction.
- Understanding TRH's central mechanisms is crucial for potential therapeutic applications.
Purpose of the Study:
- To define the sites and mechanisms by which TRH influences cardiorespiratory function in rats.
- To assess TRH's efficacy in reversing endotoxic shock-induced hypotension.
- To investigate the involvement of sympatho-medullary pathways in TRH's cardiovascular effects.
Main Methods:
- Injections of TRH into different brain ventricular spaces in conscious rats.
- Assessment of cardiorespiratory variables (mean arterial pressure, heart rate, respiratory rate) following TRH administration.
- Evaluation of TRH's effects in endotoxin-treated rats, including adrenal demedullated models.
Main Results:
- TRH injection into the third ventricle yielded greater cardiorespiratory stimulation than the fourth ventricle.
- Intracerebroventricular TRH and its analog MK 771 reversed endotoxic shock hypotension via distinct actions on heart rate and pulse pressure.
- Cardiovascular effects of intracerebroventricular TRH were dependent on adrenal medullary integrity, unlike intravenous TRH.
Conclusions:
- TRH and its analogs demonstrate potential therapeutic utility in treating shock.
- TRH acts centrally to modulate cardiorespiratory function and reverse hypotension.
- Adrenal medullary pathways are involved in the central cardiovascular effects of TRH.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:19Cardiac Output I:Effect of Heart Rate on Cardiac Output
Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...